These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20668631)

  • 21. Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
    Clin Cardiol; 2004 Mar; 27(3):169-73. PubMed ID: 15049387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
    Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
    Novo S; Abrignani MG; Novo G; Nardi E; Dominguez LJ; Strano A; Barbagallo M
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):637-43. PubMed ID: 11465647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of left ventricular hypertrophy: what have recent trials taught us?
    Verdecchia P; Angeli F
    Am J Cardiovasc Drugs; 2004; 4(6):369-78. PubMed ID: 15554722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
    Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients.
    Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H; Suzuki H
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):380-6. PubMed ID: 15076221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy?
    Fleischmann EH; Schmieder RE
    Curr Cardiol Rep; 2002 Nov; 4(6):474-8. PubMed ID: 12379166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular hypertrophy regression: the LIVE trial.
    Sheridan DJ
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function.
    Zakynthinos E; Pierrutsakos Ch; Daniil Z; Papadogiannis D
    Angiology; 2005; 56(4):439-49. PubMed ID: 16079926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta blockers & left ventricular hypertrophy regression.
    George T; Ajit MS; Abraham G
    Indian Heart J; 2010; 62(2):139-42. PubMed ID: 21180305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
    Pereira LM; Mandarim-De-Lacerda CA
    Int J Exp Pathol; 2001 Apr; 82(2):115-22. PubMed ID: 11454102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.